Aluminium, tau and Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 12, Issue 4, 2007, Pages 313-315

  Exley, Christopher ^a  

^a KEELE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; ALUMINUM CHLORIDE; AMYLOID BETA PROTEIN; HEPARIN; TAU PROTEIN;

ALZHEIMER DISEASE; BRAIN; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; DRUG CONTAMINATION; HUMAN; LETTER; NEUROLOGIC DISEASE; NEUROPATHOLOGY; PRECIPITATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STOICHIOMETRY; TRANSMISSION ELECTRON MICROSCOPY;

EID: 38049021714     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2007-12403     Document Type: Letter

References (18)

1. M. Abdel-Ghany, A.K. El-Sebae and D. Shalloway, Aluminum-induced nonenzymatic phospho-incorporation into human-tau and other proteins, J Biol Chem 268 (1993), 11976-11981.
2. D. Bohrer, P.C. do Nascimento, R. Binotto, E. Becker and S. Pomblum, Contribution of the raw material to the aluminum contamination in parenterals, J Parenteral Enteral Nutr 26 (2002), 382-388.
3. S.B. Cheknev and E.E. Babaeva, Activity of human lymphocytes in the presence of carbohydrate-containing compounds, Bull Exp Biol Med 138 (2004), 491-493.
4. C. Exley, N.C. Price, S.M. Kelly and J.D. Birchall, An interaction of β-amyloid with aluminium in vitro, FEBS Lett 324 (1993), 293-295.
5. 42 in senile plaque cores in Alzheimer's disease, J Alzh Dis 10 (2006), 173-177.
6. C. Haase, J.T. Stieler, T. Arendt and M. Holzer, Pseudophosphorylation of tau protein alters its ability for self-aggregation, J Neurochem 88 (2004), 1509-1520.
7. G.R. Harrington, C.M. Wischik, F.K. McArthur, G.A. Taylor, J.A. Edwardson and J.M. Candy, Alzheimers-disease-like changes in tau protein processing-association with aluminium accumulation in brains of renal dialysis patients, Lancet 343 (1994), 993-997.
8. 42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease, J Alzh Dis 6 (2004), 291-301.
9. G.L. Klein, The aluminum content of parenteral solutions - current status, Nutr Rev 49 (1991), 74-79.
10. 3+-induced aggregation, Neurochem Res 23 (1998), 1467-1476.
11. T.R. Madhav, S. Vatsala, T. Ramakrishna, J. Ramesh and K.R.K. Easwaran, Preservation of native conformation during aluminium-induced aggregation of tau protein, Neuroreport 7 (1996), 1072-1076.
12. M. Martinez-Estevez, V.M. Loyola-Vargas and S.M.T. Hernandez-Sotomayor, Aluminium increases phosphorylation of particular proteins in cellular suspension cultures of coffee (Coffea arabica), J Plant Physiol 158 (2001), 1375-1379.
13. T. Mizoroki, S. Meshitsuka, S. Maeda, M. Murayama, N. Sahara and A. Takashima, Aluminium induces tau aggregation in vitro but not in vivo, J Alzh Dis 11 (2007), 419-427.
14. H. Murayama, R.W. Shin, J. Higuchi, S. Shibuya, T. Muramoto and T. Kitamoto, Interaction of aluminum with PHF tau in Alzheimer's disease neurofibrillary degeneration evidenced by desferrioxamine-assisted chelating autoclave method, Am J Path 155 (1999), 877-885.
15. R.W. Shin, T.P.A. Kruck, H. Murayama and T. Kitamoto, A novel trivalent cation chelator Feralex dissociates binding of aluminium and iron associated with hyperphosphorylated tau of Alzheimer's disease, Brain Res 961 (2003), 139-146.
16. T. Takeuchi, Safni, Miwa, T. Hashimoto, Y. and H. Moriyama, Ion chromatography using anion exchangers modified with heparin, Analusis 26 (1998), 61-64.
17. D.B. Volkin, A.M. Verticelli, K.E. Marfia, C.J. Burke, H. Mach and C.R. Middaugh, Sucralfate and soluble sucrose octasulfate bind and stabilize acidic fibroblast growth-factor, Biochim Biophys Acta 1203 (1993), 18-26.
18. Y. Yoshiike, K. Tanemura, O. Murayama, T. Akagi, M. Murayama, S. Sata, X. Sun, N. Tanaka and A. Takashima, New insights on how metals disrupt amyloid β-aggregation and their effects on amyloid-β cytotoxicity, J Biol Chem 276 32293-32299.